UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 177 filers reported holding UNIQURE NV in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $767 | -12.8% | 39,400 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $880 | -99.9% | 39,400 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $694,000 | -2.8% | 39,400 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $714,000 | +1.4% | 39,400 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $704,000 | -18.4% | 39,400 | -7.1% | 0.00% | 0.0% |
Q4 2021 | $863,000 | -33.0% | 42,400 | +2.7% | 0.00% | -50.0% |
Q3 2021 | $1,288,000 | +1.7% | 41,300 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $1,266,000 | -6.8% | 41,300 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $1,359,000 | +130.7% | 41,300 | +153.4% | 0.01% | +150.0% |
Q4 2020 | $589,000 | -3.0% | 16,300 | -4.7% | 0.00% | -33.3% |
Q3 2020 | $607,000 | +52.1% | 17,100 | +69.3% | 0.00% | +50.0% |
Q3 2019 | $399,000 | -73.8% | 10,100 | -50.0% | 0.00% | -75.0% |
Q2 2019 | $1,520,000 | +192.3% | 20,200 | +64.2% | 0.01% | +166.7% |
Q1 2019 | $520,000 | +99.2% | 12,300 | +21.8% | 0.00% | +50.0% |
Q4 2018 | $261,000 | -49.8% | 10,100 | -17.9% | 0.00% | -33.3% |
Q3 2018 | $520,000 | +7.0% | 12,300 | -2.4% | 0.00% | 0.0% |
Q2 2018 | $486,000 | +62.5% | 12,600 | 0.0% | 0.00% | +50.0% |
Q1 2018 | $299,000 | +112.1% | 12,600 | +5.0% | 0.00% | 0.0% |
Q1 2016 | $141,000 | – | 12,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |